Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Tran cannula versus augmented irrigation during cataract surgery for pseudoexfoliative glaucoma

Official title: Efficacy and Safety of Tran Cannula in Combined Pseudoexfoliative Glaucoma and Cataract Surgery Compared With Augmented Ocular Irrigation

Run by Hôpital Privé de la Baie · NCT06979752 · Data updated 2026-11-12

This study will test whether using the single-use Tran cannula during cataract surgery lowers intraocular pressure more than increased irrigation for people with early-to-moderate pseudoexfoliative glaucoma.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment58 (estimated)
SponsorHôpital Privé de la Baie
Academic / other
Locations3 sites (Avranches and 2 other locations)
StatusRecruiting
StartedJune 4, 2025
Main results expectedFebruary 2, 2028
Study endsFebruary 2, 2029
Registry record updatedSeptember 30, 2026
Trial IDNCT06979752 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people with early-to-moderate pseudoexfoliative open-angle glaucoma who need isolated cataract surgery and have untreated intraocular pressure between 21 and 33 mmHg.

Probably not a fit

Patients with advanced glaucoma, angle-closure glaucoma, other significant ocular disease, recent intraocular surgery or laser, or very poor visual acuity are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Patients with early-to-moderate pseudoexfoliative open-angle glaucoma scheduled for isolated cataract surgery will receive either cleaning with the single-use Tran cannula or augmented ocular irrigation during the procedure. The Tran cannula is designed to clear pseudoexfoliative material from the trabecular meshwork, and investigators will compare postoperative intraocular pressure and safety between the two approaches. Eligible participants must have typical glaucomatous field and OCT changes, open angles by gonioscopy, and untreated eye pressure between 21 and 33 mmHg. Follow-up will monitor IOP outcomes and procedure-related complications.

Why it matters

Potential benefit: If successful, the Tran cannula could produce greater and more sustained IOP lowering after cataract surgery, potentially slowing glaucoma progression and reducing medication needs.

How similar studies have gone: Irrigation and flushing approaches to remove exfoliative material have been explored previously, but the specific single-use Tran cannula device is relatively new and not yet widely validated in large studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with cataract and early-to-moderate pseudoexfoliative glaucoma (GPX) scheduled for isolated cataract surgery.
* Reliable visual field, Humphrey 24-2, Sita-Fast, with typical glaucoma alterations, and with mean deviation ≤-12 dB.
* OCT with ganglion cell alterations and fibers typical of glaucoma.
* Typical glaucomatous neuropathy
* Slit-lamp signs of pseudoexfoliation.
* Open angle (2 to 4, according to Shaffer classification) determined by gonioscopy.
* Untreated eye pressure \>21 mmHg and \<33 mmHg

Exclusion Criteria:

* Presence of other ophthalmological pathologies (except cataract or mild dry eye)
* History of intraocular surgery in the last 12 months, history of trauma
* History of laser trabeculoplasty (TLA or SLT) in the previous 12 months
* Visual acuity below "finger count
* Myopia ≥ 6 dioptres, hyperopia ≥ 5 dioptres
* Iridocorneal angle closure (and angle-closure glaucoma), any other type of non-pseudoexfoliative glaucoma, iris neovascularization
* Pachymetry \< 490 μm or \> 620 μm; or corneal pathology or other condition that makes accurate IOP measurements with flattening tonometry, ultrasonic pachymetry or specular microscopy impossible.
* Presence of severe systemic pathologies

Where it's running

  • Hôpital Privé de la Baie
    Avranches, France
    Recruiting
  • Fondation Rothschild
    Paris, France
    Active not recruiting
  • Clinique de la Côte d'Emeraude
    St-Malo, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.